Type:
Educational Exhibit
Keywords:
Education and training, Structured reporting, MR-Functional imaging, MR, Pelvis, Oncology, Genital / Reproductive system male
Authors:
E. C. Nganga, D. Kazzaz, D. ap Dafydd; London/UK
DOI:
10.1594/ecr2018/C-0437
References
1.
UK CR.
Prostate cancer statistics.
2014.
2.
Barrett T.
What is Multiparametric-MRI of the Prostate and Why Do We Need It? 2015.
3.
Steiger P,
Thoeny HC.
Prostate MRI based on PI-RADS version 2: how we review and report.
Cancer Imaging.
2016;16(1):9.
4.
Graham J,
Kirkbride P,
Cann K,
Hasler E,
Prettyjohns M.
Prostate cancer: summary of updated NICE guidance.
BMJ: British Medical Journal (Online).
2014;348.
5.
Radiology ACo.
PIRADS v2.
Reston,
VA: American College of Radiology.
2014.
6.
Vargas HA,
Hötker AM,
Goldman DA,
Moskowitz CS,
Gondo T,
Matsumoto K,
et al.
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
European Radiology.
2016;26(6):1606-12.
7.
de Rooij M,
Hamoen EH,
Fütterer JJ,
Barentsz JO,
Rovers MM.
Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis.
American Journal of Roentgenology.
2014;202(2):343-51.
8.
Harada T,
Abe T,
Kato F,
Matsumoto R,
Fujita H,
Murai S,
et al.
Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma.
BMC Urology.
2015;15(1):91.